Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 5, 2017SHILAP Revista de lepidopterologíaOpen Access

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding

View Full Paper
Ask AI
Bookmark
Share

Authors

DLDaniel LindholmHeart Failure & TransplantEmil HagströmEmil HagströmPreventive CardiologyStefan JamesStefan JamesInterventional Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lindholm et al. (2017) studied this question.

synapsesocial.com/papers/69cec2f8e84115fc29c51ecbhttps://doi.org/10.1161/jaha.117.005580

Topics

Dual antiplatelet therapy
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes2007 · 6,825 citations
  2. 2Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease2016 · 569 citations
  3. 3Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non–ST-Elevation Acute Coronary Syndrome2016 · 35 citations
  4. 4Change in Growth Differentiation Factor 15 Concentrations over Time Independently Predicts Mortality in Community-Dwelling Elderly Individuals2013 · 114 citations
  5. 5Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes2009 · 7,160 citations